Firneisz G - Search Results

1

Identification and Potential Clinical Utility of the MTNR1B rs10830963 Core Gene Variant Associated to Endophenotypes in Gestational Diabetes Mellitus.

Firneisz G, Rosta K, Rigó J, Nádasdi Á, Harreiter J, Kautzky-Willer A, Somogyi A. Firneisz G, et al. Front Genet. 2020 Apr 21;11:332. doi: 10.3389/fgene.2020.00332. eCollection 2020. Front Genet. 2020. PMID: 32373162 Free PMC article. No abstract available.

2

[Elevated serum dipeptidyl peptidase-4 activity in type 1 diabetes mellitus: a direct comparison].

Varga T, Firneisz G, Nagy G, Somogyi A. Varga T, et al. Among authors: firneisz g. Orv Hetil. 2010 May 30;151(22):899-902. doi: 10.1556/OH.2010.28842. Orv Hetil. 2010. PMID: 20478811 Hungarian.

3

Serum dipeptidyl peptidase-4 activity in insulin resistant patients with non-alcoholic fatty liver disease: a novel liver disease biomarker.

Firneisz G, Varga T, Lengyel G, Fehér J, Ghyczy D, Wichmann B, Selmeci L, Tulassay Z, Rácz K, Somogyi A. Firneisz G, et al. PLoS One. 2010 Aug 18;5(8):e12226. doi: 10.1371/journal.pone.0012226. PLoS One. 2010. PMID: 20805868 Free PMC article.

4

Higher serum DPP-4 enzyme activity and decreased lymphocyte CD26 expression in type 1 diabetes.

Varga T, Somogyi A, Barna G, Wichmann B, Nagy G, Rácz K, Selmeci L, Firneisz G. Varga T, et al. Among authors: firneisz g. Pathol Oncol Res. 2011 Dec;17(4):925-30. doi: 10.1007/s12253-011-9404-9. Epub 2011 Jul 22. Pathol Oncol Res. 2011. PMID: 21785903 Free article.

5

Serum level of soluble CD26/dieptidyl peptidase-4 (DPP-4) activity correlates with other liver disease biomarkers both in Asian and European patients.

Firneisz G, Somogyi A. Firneisz G, et al. Transl Res. 2012 Jul;160(1):95-6. doi: 10.1016/j.trsl.2012.01.016. Epub 2012 Feb 7. Transl Res. 2012. PMID: 22683411 No abstract available.

6

[Type 1 diabetes mellitus: most recent advances in its pathogenesis and treatment].

Zóka A, Somogyi A, Firneisz G. Zóka A, et al. Among authors: firneisz g. Orv Hetil. 2012 Jul 8;153(27):1047-56. doi: 10.1556/OH.2012.29413. Orv Hetil. 2012. PMID: 22759745 Review. Hungarian.

7

Altered immune regulation in type 1 diabetes.

Zóka A, Műzes G, Somogyi A, Varga T, Szémán B, Al-Aissa Z, Hadarits O, Firneisz G. Zóka A, et al. Among authors: firneisz g. Clin Dev Immunol. 2013;2013:254874. doi: 10.1155/2013/254874. Epub 2013 Aug 21. Clin Dev Immunol. 2013. PMID: 24285974 Free PMC article. Review.

8

Extension of the CD4⁺Foxp3⁺CD25(-/low) regulatory T-cell subpopulation in type 1 diabetes mellitus.

Zóka A, Barna G, Somogyi A, Műzes G, Oláh Á, Al-Aissa Z, Hadarits O, Kiss K, Firneisz G. Zóka A, et al. Among authors: firneisz g. Autoimmunity. 2015;48(5):289-97. doi: 10.3109/08916934.2014.992518. Epub 2014 Dec 19. Autoimmunity. 2015. PMID: 25523632 Free article.

9

Cord serum dipeptidyl-peptidase 4 activity in gestational diabetes.

Al-Aissa Z, Rosta K, Hadarits O, Harreiter J, Zóka A, Bancher-Todesca D, Patócs A, Kiss K, Sármán B, Pusztai P, Sziller I, Rigó J, Rácz K, Somogyi A, Kautzky-Willer A, Firneisz G. Al-Aissa Z, et al. Among authors: firneisz g. Eur J Clin Invest. 2015 Feb;45(2):196-203. doi: 10.1111/eci.12397. Eur J Clin Invest. 2015. PMID: 25556541

10

Altered crosstalk in the dipeptidyl peptidase-4-incretin-immune system in type 1 diabetes: A hypothesis generating pilot study.

Zóka A, Barna G, Hadarits O, Al-Aissa Z, Wichmann B, Műzes G, Somogyi A, Firneisz G. Zóka A, et al. Among authors: firneisz g. Hum Immunol. 2015 Sep;76(9):667-72. doi: 10.1016/j.humimm.2015.09.018. Epub 2015 Oct 3. Hum Immunol. 2015. PMID: 26434625

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

56 results

Search Page

Filters